$GlaxoSmithKline (GSK.US)$ Very poor performance stock. Not ...
$GlaxoSmithKline(GSK.US$ Very poor performance stock. Not suprise in the end of 2024, it will be worth around $25
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment